Taken together, this demonstrates that the increased rate of wound closure observed in the T286D phosphomimic mutant overexpressing breast cancer cells (Fig. 4A,B) was not due to increased proliferative capacity, but that T286D phosphomimic mutation of CaMKII increases the migratory capability of breast cancer cells, without altering proliferation rates. Here, CAMK2G is linked to breast carcinoma.